Inflammatory Bowel Diseases  >>  andecaliximab (GS-5745)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
andecaliximab (GS-5745) / Gilead
NCT02209987: Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults

Completed
1
28
RoW
GS-5745 SC, GS-5745 IV
Gilead Sciences
Ulcerative Colitis
10/14
10/14

Download Options